
Pharming Group NV
@pharminggroupnv
Pharming develops innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.
HAE-GLO-2021-0008
ID: 1397896282027474948
https://www.pharming.com/ 27-05-2021 12:43:58
66 Tweet
335 Followers
0 Following




Pharming Group NV reports on the results of the 2023 Extraordinary General Meeting of Shareholders and welcomes Dr. Richard Peters. Please click on the link below to read the press release in full. bit.ly/3tbzcEs #EGM2023 #pharminggroup


Pharming Group NV will report its 3Q 2023 financial results on Thursday, October 26, 2023, at 07:00 CEST. We will hold our conference call and webcast at 13:30 CEST/07:30 EDT. Please click on the link for info: bit.ly/3ZQ06xI #3Q23 #pharminggroup #financialresults


This morning Pharming Group NV published its third quarter 2023 financial results. To read the press release please click here: bit.ly/3SeR1N7 Management will hold an analyst & investor call today October 26 at 13:30 CEST/07:30 EDT #3Q23 #financialresults #pharminggroup


We are happy to share that Pharming Group NV management will participate in the #Jefferies London Healthcare Conference in the month of November. bit.ly/46OM2XY To schedule a meeting with management, reach out to [email protected] #jefferieshealthcare #pharminggroup



Pharming Group NV is pleased to welcome Daniela Dos Anjos Hanova as our new Chief People Officer (CPO) and member of the Executive Committee as of today. For more information please visit our website: bit.ly/3MthLpm






For investors and medical media: Today, Pharming Group NV announces expansion of its rare disease pipeline with plans to develop its PI3K delta inhibitor for additional (PIDs) with immune dysregulation linked to PI3Káș signaling. bit.ly/3GHiP5M #pharminggroup #APDS #PID





The Pharming Group NV management team is in San Francisco this week. Contact [email protected] or [email protected] to schedule a meeting. #JPM2024


For Investors and Media: today, Pharming Group NV announces updated full year 2023 guidance and U.S. launch update bit.ly/3TRArDT


We are happy to share that Pharming Group NV management will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference and the UBS European Healthcare Conference in the month of February. bit.ly/3HOwHf0 #conference2024 #biopharma #pharminggroup
